Structural Adhesive Market Advanced Technologies and Growth Opportunities Worldwide By 2030

 Structural Adhesive Market Growth & Trends

The global structural adhesive market size is expected to reach USD 31.9 billion by 2030, as per the new report by Grand View Research, Inc., registering a CAGR of 5.8% from 2022 to 2030. The demand for the product is attributed to the rise in the consumption of the product in the construction, transportation, and consumer appliances industries. Additionally, it is utilized in creating a bond between metals, plastics, foams, and fabrics in furniture.

Adhesives are extensively used in the majority of day-to-day products. The furniture industry uses several types of adhesives such as polyvinyl acetate, synthetic rubber-based adhesive, cyanoacrylates, chloroprene rubber, and epoxy. Factors such as growing demand for hybrid and durable rubber and rising inclination toward modular and compact furniture are anticipated to drive the furniture industry, leading to the growth of the market during the forecast period.

Several advantages of adhesives such as high flexibility, lightness, chemical, corrosion & dust resistance, and compatibility with varied substances are anticipated to drive the demand for the product from the construction industry in HVAC, roofing, cables, floorings, windows, carpet, and others.

The market growth was negatively impacted for a short period due to COVID-19 owing to the shutting down of manufacturing plants in the automotive, industrial, and construction sectors. The demand fluctuations from these end-use industries had a direct impact on structural adhesives. Additionally, the lockdown impacted the industrial construction sector owing to the slowdown in construction activities.

Companies are continuously involved in the expansion of manufacturing plants in order to ensure a quick supply of their products to customers and enhance the production capacity of the product. For instance, Henkel AG & Co., AGaA opened its new manufacturing plant in Mexico to ensure the timely availability of the products to the customers.

Request a free sample copy or view report summary: Structural Adhesive Market Report

Structural Adhesive Market Report Highlights

• The water-based technology segment is expected to expand at a lucrative CAGR of 6.0% during the forecast period based on revenue owing to an increase in its bonding applications in leather, wood, and textiles
• The epoxy product segment is expected to expand at a significant CAGR of 6.2% from 2022 to 2030 based on revenue as it ensures high strength towards permanent bonding applications
• The construction application segment is anticipated to register a revenue-based CAGR of 5.8% during the forecast period due to the rise in the consumption of the product in residential and commercial construction activities
• Asia Pacific region is anticipated to register the fastest CAGR of 6.3% during the forecast period based on revenue owing to a rise in the industrial output in China, India, and Southeast Asia
• The growth of the North American construction industry is largely supported by the rapid expansion of the residential housing sector. The construction sector in the U.S. has outperformed Mexico and Canada in the past few years
• Companies have been boosting their production capacities in order to keep up with the rising demand from the end-use industries such as construction and transportation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-structural-adhesives-market

Structural Adhesive Market Segmentation

Grand View Research has segmented the global structural adhesive market based on product, technology, application, and region:

Structural Adhesive Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Urethanes
• Epoxy
• Acrylic
• Cyanoacrylic
• Others

Structural Adhesive Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Water-based
• Solvent-based
• Others

Structural Adhesive Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• Transportation
• Construction
• Consumer Appliances
• Furniture
• Others

Structural Adhesive Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • Korea
• Central & South America
  • Brazil
• Middle East & Africa

List of Key Players of the Structural Adhesive Market

• Henkel AG & Co. KGaA
• Dow
• 3M
• B. Fuller Company
• Franklin International
• AVERY DENNISON CORPORATION
• Ashland
• Lord Corporation (Parker Hannifin Corp.)
• Arkema
• Hubei Huitian Adhesive Enterprise Co., Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Monkeypox Vaccine And Treatment Market to Reflect a Holistic Expansion During 2022 to 2030: Grand View Research Inc.

 Monkeypox Vaccine And Treatment Market Growth & Trends

The global monkeypox vaccine and treatment market size is expected to reach USD 184.79 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.16% from 2022 to 2030. The growing government initiatives for combating the monkeypox virus threat and a surge in awareness about the disease are the major factors driving the market. Moreover, an increase in R&D activities to develop vaccines and treatments is expected to fuel market growth.

The incidence rate of infection is higher in men as compared to women. According to the CDC’s data of August 2021, the monkeypox virus affected over 2,231 men of age 31 to 35 as compared to 11 women of age 31 to 35. The infection rate of the virus is more common in people between 20 to 50 years of age. Thus, the rising infection rates from the monkeypox virus are anticipated to fuel the demand for novel and effective treatment.

The increasing funding for boosting research activities and expanding manufacturing capacities of vaccine plants is likely to fuel market demand. For instance, in August 2022, the U.S. Department of Health and Human Services announced a funding of USD 11 million for providing support to fill and finish the manufacturing of JYNNEOS vaccine approved for preventing monkeypox and smallpox at GRAM, Michigan. This funding will assist GRAM to purchase extra equipment for JYNNEOS production.

Moreover, in July 2022, the pandemic institute awarded funding of around USD 580,049 to Liverpool researchers for managing the global threat of monkeypox. The funding is awarded for promoting research activities for understanding the stigma around the disease and developing new treatment regimens.

Furthermore, various strategic initiatives undertaken by the leading market players to strengthen their portfolio and market footprint are expected to facilitate market expansion. For instance, in August 2022, Bavarian Nordic A/S announced an agreement with Pan American Health Organization to boost equitable access to the Bavarian Nordic A/S monkeypox vaccine for countries in the Caribbean and Latin America. The vaccine delivery is likely to commence in the month of September.

In addition, in May 2022, SIGA Technologies, Inc. announced that its IV formulation TPOXX (tecovirimat) received U.S. FDA approval for the treatment of smallpox. The intravenous formulation is an alternative for patients who cannot swallow the oral formulation of the TPOXX. The IV formulation of TPOXX is also being used to manage the symptoms of monkeypox in the U.S.

However, the chances of side effects from the vaccine may hinder the market growth in the coming years. Some of the common side effects associated with the monkeypox vaccine include induration, muscle pain, swelling, nausea, and itching, among others.

Request a free sample copy or view report summary: Monkeypox Vaccine And Treatment Market Report

Monkeypox Vaccine And Treatment Market Report Highlights

• Based on product, the drugs segment held the largest share in 2022 owing to ongoing product approvals and increasing demand for antiviral drugs for the treatment
• The male segment accounted for the largest share in 2022 due to the higher prevalence of infections among men
• By route of administration, the oral segment dominated the market in 2022 due to the increased demand for oral antiviral drugs for the treatment of monkeypox disease
• The hospitals segment was the largest segment in 2022. The specialty clinics segment is anticipated to register the fastest growth rate throughout the forecast period
• Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the increased risk of monkeypox infections and increasing awareness about vaccination

Access Press Release@ https://www.grandviewresearch.com/press-release/global-monkeypox-vaccine-treatment-market

Monkeypox Vaccine And Treatment Market Segmentation

Grand View Research has segmented the global monkeypox vaccine and treatment market based on product, gender, route of administration, end-use, and region:

Monkeypox Vaccine And Treatment Product Outlook (Revenue, USD Million, 2022 - 2030)

• Vaccine
  • JYNNEOS/Imvanex
  • Smallpox Vaccine
  • Others
• Drugs
  • Tecovirimat
  • Brincidofovir
  • Cidofovir
  • Others
• Vaccinia Immune Globulin (VIG)

Monkeypox Vaccine And Treatment Gender Outlook (Revenue, USD Million, 2022 - 2030)

• Male
• Female
• Others

Monkeypox Vaccine And Treatment Route of Administration Outlook (Revenue, USD Million, 2022 - 2030)

• Oral
• Injectable

Monkeypox Vaccine And Treatment End-use Outlook (Revenue, USD Million, 2022 - 2030)

• Hospitals
• Specialty Clinics
• Others

Monkeypox Vaccine And Treatment Regional Outlook (Revenue, USD Million, 2022 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Monkeypox Vaccine And Treatment Market

• Bavarian Nordic
• SIGA Technologies
• Chimerix
• EMERGENT
• Gilead Sciences, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ingestible Sensors Market Size, Industry Share And Growth Analysis For 2023-2030: Grand View Research Inc.

 Ingestible Sensors Market Growth & Trends

The global ingestible sensors market size is expected to reach USD 1.8 billion by 2030, registering a CAGR of 10.90% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing need for medical adherence and real-time monitoring of health along with the rising prevalence of chronic diseases are some of the factors driving the market growth. Furthermore, improvement in patient compliance to treatment is boosting the usage of ingestible sensors.

Increasing research on using smart pills for the detection of gut diseases, cancer, and others.is likely to favor market growth. In July 2020, a team of researchers at the University of Saskatchewan received USD 250,000 from the federal New Frontiers in Research Fund for research on an AI-enabled capsule intended for the early diagnosis of gastrointestinal cancers. Smart-Cap consists of wireless biosensors that can analyze targeted cancer biomarkers and locate tumors and bleeding, resulting in greater accuracy.

Rising cases of chronic diseases, such as diabetes, hypertension, and cancer have also led to market expansion. According to the International Diabetes Federation (IDF), around 783 million people across the world are projected to have diabetes by 2045. In addition; the growing geriatric population is also leading to numerous health issues, which is further rising the incidences of such chronic diseases.

With technological advancements, ingestible sensors are growing rapidly in the field of digital medicine. Thus, they are anticipated to grow further in the applications like customized drug delivery. However, costly raw materials and techniques for the development and design of this product may impede market growth.

COVID-19 has had a negative impact on the ingestible sensors market owing to transportation restrictions, delays in raw material procurement, and a decline in endoscopy procedures. The situation is now stabilizing as key players are adopting new strategies to drive market growth. For instance, in September 2020, CapsoVision Inc. announced that the US FDA will apply enforcement discretion to allow patients, who are determined to be eligible for at-home administration of the CapsoCam Plus small bowel capsule endoscope, during the COVID-19.

Request a free sample copy or view the report summary: Ingestible Sensors Market Report

Ingestible Sensors Market Report Highlights

• In 2022, the temperature sensorssegment led the market owing to their benefits in diagnosing and treating heat-related illnesses, particularly among athletes
• The imagesensors segment is projected to show significant growth during the forecast period due to their accuracy and clear images for the diagnosis of critical diseases
• Based on component, sensors held the largest revenue share in 2022, owing to the advanced and expensive technology used in these devices and increasing research to use them for the diseases diagnosis
• The medical segment accounted for the largest revenue share in 2022 owing to the high use of edible sensors in drug delivery and patient monitoring plus the rising prevalence of chronic diseases
• North America held the largest revenue share in 2022 due to the greater acceptance of advanced technologies
• Asia Pacific is anticipated to register a significant CAGR during the forecast period on account of the increasing geriatric population and prevalence of chronic diseases, especially in the developing countries
• Key players are contributing to the growth of the market through research, collaboration, and partnerships. For instance, in January 2021, etectRx partnered with Pear Therapeutics for the development of two products that will combine etectRx’s ingestible sensors with Pear’s digital therapeutics

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ingestible-sensors-market

Ingestible Sensors Market Segmentation

Grand View Research has segmented the global ingestible sensors market based on the component, sensor type, vertical, and region:

Ingestible Sensors Component Outlook (Revenue, USD Million, 2017 - 2030)

• Sensors
• Wearable Patch/Data Recorder
• Software

Ingestible Sensors Sensor Type Outlook (Revenue, USD Million, 2017 - 2030)

• Temperature Sensor
• Pressure Sensor
• pH Sensor
• Image Sensor

Ingestible Sensors Vertical Outlook (Revenue, USD Million, 2017 - 2030)

• Medical
• Sports And Fitness
• Others

Ingestible Sensors Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Ingestible Sensors Market include

• Olympus Corporation
• Otsuka Holdings Co., Ltd.
• Medtronic
• etectRx
• CapsoVision, Inc.
• Q., Inc.
• IntroMedic
• JINSHAN Science & Technology
• Check-Cap

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Radiology Information Systems Market Trends Regulations And Competitive Landscape Outlook to 2030

 Radiology Information Systems Market Growth & Trends

The global radiology information systems market size is expected to reach USD 1.9 billion by 2030, registering a CAGR of 10.19% from 2023 to 2030, according to a new report by Grand View Research, Inc. This market growth is driven by the factors such as the increasing incidences of chronic diseases and the adoption of advanced technologies in healthcare facilities. The growing usage of digital healthcare infrastructure, which helps collect and manage information generated by hospitals, clinics, and institutes, has enhanced the efficiency and effectiveness of their services.

The integration of Artificial Intelligence (AI) into radiology information system (RIS) offers lucrative growth opportunities for the market. This will result in smoother workflows, better patient care, and consistent support for radiologists. It also helps radiologists to deliver a coordinated ecosystem experience to make faster, more accurate, and more consistent diagnoses. Additionally, government initiatives to increase the adoption of RIS are expected to boost market growth.

An increasing number of medical imaging tests for various diseases is anticipated to drive the growth of the market. As per Harvard Health, around 80 million CT scans were performed in the U.S. annually. Furthermore, the number of radiology labs and increasing installations of MRI and CT scans have created the demand for RIS in hospitals.

COVID-19 slowed the growth of the market. This was mainly due to the decline in the number of non-urgent medical imaging procedures during the first wave. However, patient volumes recovered strongly in the second half. Many government organizations recommended radio-imaging tests for the detection of black fungus among COVID-19 patients. This positively impacted growth of the market in 2021.

Request a free sample copy or view the report summary: Radiology Information Systems Market Report

Radiology Information Systems Market Report Highlights

• Based on deployment mode, the web-based segment held the largest revenue share in 2022, due to workflow enhancement features such as scheduling, document imaging, automated insurance eligibility functions, and billing
• Based on product, the integrated RIS segment accounted for the largest market share in the year 2022. It offers data analysis with the help of Picture Archiving and Communication System (PACS) for the development of IT service models
• Hospitals, emergency healthcare service providers, and physicians are a few RIS end-users. Hospitals majorly prefer radiology solutions for patient scheduling, and appointments, along with tracking patient history and records
• North America led the radiology information systems market in 2022 in terms of revenue attributed to the technological advancements and presence of major market players
• In July 2021, Kestral, an Australia RIS company, Aceso Health, a healthcare solution provider in New Zealand, and Sorsix Technologies entered into a multi-year collaboration. Under the terms of the agreement, the companies will combine Aceso's Snap scan Patient Online Booking System with Kestral's Karisma RIS.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-radiology-information-system-ris-market

Radiology Information Systems Market Segmentation

Grand View Research has segmented the global radiology information systems market based on the deployment mode, product, and end-use.

RIS Deployment Mode Outlook (Revenue, USD Million, 2016 - 2030)

• Web-based
• On-premise
• Cloud-based

RIS Product Outlook (Revenue, USD Million, 2016 - 2030)

• Integrated RIS
• Standalone RIS

RIS End-Use Outlook (Revenue, USD Million, 2016 - 2030)

• Hospitals & Clinics
• Outpatient Department (OPD)
• Others

RIS Regional Outlook (Revenue, USD Billion, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players in Radiology Information Systems (RIS) Market

• Oracle
• General Electric Company
• IBM
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• All scripts Healthcare, LLC
• Epic Systems Corporation
• McKesson Corporation
• MedInformatix, Inc.
• eRAD
• Pro Medicus, Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Corporate Wellness Market Witness Excellent Revenue Growth During 2023-2030: Grand View Research Inc

 Corporate Wellness Market Growth & Trends

The global corporate wellness market size is expected to reach USD 74.9 billion by 2030, expanding at a CAGR of 4.47% during the forecast period, based on a new report by Grand View Research, Inc. Rising obese and overweight population increases insurance costs that account for the financial burden on employers. Corporate wellness initiatives target particular health risk factors such as stress, obesity, smoking, poor eating, and lack of exercise.

The pandemic has caused a change in the process of delivering wellness services. Although in-person sessions have resumed to some extent, the virtual platform has been made available to at-risk employees to meet their psychological and fitness needs. Initially, the lockdown imposed due to COVID-19 resulted in a transition to work from home, causing a great deal of stress. Companies around the globe are modifying their corporate wellness strategies to meet the emerging public health crisis due to COVID-19.

Organizations are increasingly using corporate wellness programmes to boost employee health and productivity, mitigate health risks, and minimize employee healthcare expenses. Businesses are more conscious of the importance of maintaining a psychologically and physically healthy workforce. As a result, capital investment in employee wellness programmes, solutions, and services has surged. Absenteeism expenses are reduced by USD 2.7 for every dollar spent on fitness programmes, according to a study conducted by Harvard economists. As a direct consequence, employees must be encouraged to live a healthier lifestyle in order to perform better.

Employers providing the programs have noticed a significant rise in productivity and a decline in leaves and attrition. In addition, companies in the U.K. initiated the Fit for Work service, which offers a tax benefit of USD 663.3 per year. Organizations are providing wearables, such as Fitbit, Apple, and Google watches, which helps in keeping track of parameters such as heart rate and blood pressure.

Moreover, the International Labor Organization (ILO) estimates that the Asia-Pacific employs 1.9 billion people. Globalization has led in significant economic expansion throughout the region, with most countries experiencing a continuous increase in the number of employees. Additionally, the region's workforce is aging, with the region's population aged 60 and over predicted to grow by 24% by 2050, according to the United Nations report. This would result in an increase in the burden of chronic diseases among the region's working population in the following years. These factors create a potential for the market to grow in emerging countries throughout the forecast period.

Request a free sample copy or view report summary: Corporate Wellness Market Report

Corporate Wellness Market Report Highlights

• In terms of service, the health risk assessment segment dominated the corporate wellness market in 2022. The health assessment activities enable employers to implement strategic initiatives to deal with the identified health risks
• The stress management segment is likely to showcase the fastest growth rate from 2023 to 2030, owing to the rising preference for on-site yoga and meditation services and the rising prevalence of depression and anxiety due to the COVID-19 pandemic.
• Based on End-Use, large scale organizations segment dominated the market in 2022. The infrastructure in large scale companies makes conducting fitness services easier and convenient
• North America dominated the market in 2022 due to the popularity of corporate wellness in the region. According to a survey by Benefits Canada conducted on 1300 employers, North America had the highest number of corporate wellness programs. More than 80.0% of the employers in North America are offering corporate wellness services to their employees

Access Press Release@ https://www.grandviewresearch.com/press-release/global-corporate-wellness-market

Corporate Wellness Market Segmentation

Grand View Research has segmented the global corporate wellness market based on service, end-use, category, delivery model, and region:

Corporate Wellness Service Outlook (Revenue, USD Million, 2016 - 2030)

• Health Risk Assessment
• Fitness
• Smoking Cessation
• Health Screening
• Nutrition & Weight Management
• Stress Management
• Others

Corporate Wellness End-Use Outlook (Revenue, USD Million, 2016 - 2030)

• Small Scale Organizations
• Medium Scale Organizations
• Large Scale Organizations

Corporate Wellness Category Outlook (Revenue, USD Million, 2016 - 2030)

• Fitness & Nutrition Consultants
• Psychological Therapists
• Organizations/Employers

Corporate Wellness Delivery Model Outlook (Revenue, USD Million, 2016 - 2030)

• Onsite
• Offsite

Corporate Wellness Regional Outlook (Revenue, USD Million, 2016 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Corporate Wellness Market

• ComPsych
• Wellness Corporate Solutions
• Virgin Pulse
• EXOS
• Marino Wellness
• Privia Health
• Vitality
• Wellsource, Inc.
• Central Corporate Wellness
• Truworth Wellness
• SOL Wellness

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

General Surgery Devices Market to Reflect Impressive Expansion During 2022 to 2030: Grand View Research Inc.

 General Surgery Devices Market Growth & Trends

The global general surgery devices market size is expected to reach USD 29.96 billion by 2030, registering a CAGR of 8.29% over the forecast period, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures coupled with technological advancements is anticipated to drive the market. Moreover, increasing awareness and patient affordability for plastic or reconstructive surgeries would propel the number of procedures conducted. Technological advancements in the field of general surgery are considered key drivers of this industry. Several key players are investing in R&D for the launch of innovative products. For instance, the development of medical robots to assist surgeons is a key advancement in the field.

Medical robots offer several advantages, such as a 3D view of the operating field, reduced blood loss & transfusions, early discharge from the hospital, lower risk of infection, faster recovery time, minimal scarring, less trauma to the body & less postoperative pain, more precision in surgery due to the elimination of a surgeon’s tremor. Furthermore, an increase in the number of road accidents, an aging population, and rising healthcare expenditure in emerging economies are also among the key factors expected to boost industry growth. The geriatric population is more susceptible to a vast number of diseases, which is likely to increase the need to treat the diseases effectively, thereby boosting industry growth. According to the U.S. Census Bureau, healthcare spending worldwide is anticipated to increase to USD 18.28 trillion by 2040, growing at a CAGR of 2.6%.

Request a free sample copy or view report summary: General Surgery Devices Market Report

General Surgery Devices Market Report Highlights

• North America accounted for the largest revenue share in 2021 owing to favorable reimbursement policies, the presence of key companies, and government initiatives
• The Asia Pacific region is estimated to register the fastest CAGR during the forecast period due to advancing technology, increasing investment, improving reimbursement scenarios, and growing medical tourism
• The disposable surgical supplies segment led the industry in 2021 owing to the high demand for disposable supplies, such as needles, syringes, and catheters
• The medical robotics & computer-assisted surgery devices segment is projected to register a CAGR from 2022 to 2030 due to high investments in R&D, availability of technologically advanced products, and a rise in their adoption
• The orthopedic surgery segment held the largest share in 2021 due to the increased cases of bone diseases and the high geriatric population across the globe
• In 2021, the hospitals end-use segment accounted for the fastest revenue share during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-general-surgery-devices-market

General Surgery Devices Market Segmentation

Grand View Research has segmented the global general surgery devices market on the basis of type, application, end-use, and region:

General Surgery Devices Type Outlook (Revenue, USD Million, 2017 - 2030)

• Disposable Surgical Supplies
  • Surgical Non-woven
    • Disposable Surgical Masks
    • Surgical Drapes
    • Surgical Caps
    • Surgical Gowns
  • Examination & Surgical Gloves
  • General Surgery General Surgery Procedural Kits
  • Needles and Syringes
  • Venous Access Catheters
• Open Surgery Instrument
  • Retractor
  • Dilator
  • Catheters
• Energy-based & Powered Instrument
  • Powered Staplers
  • Drill System
• Minimally Invasive Surgery Instruments
  • Laparoscope
  • Organ Retractor
• Medical Robotics & Computer Assisted Surgery Devices
• Adhesion Prevention Products

General Surgery Devices Application Outlook (Revenue, USD Million, 2017 - 2030)

• Orthopedic Surgery
• Cardiology
• Ophthalmology
• Wound Care
• Audiology
• Thoracic Surgery
• Urology & Gynecology Surgery
• Plastic Surgery
• Neurosurgery
• Others

General Surgery Devices End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

General Surgery Devices Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of General Surgery Devices Market

• Medtronic Plc
• Johnson & Johnson Service, Inc.
• Conmed Corp.
• Integra LifeSciences
• Smith & Nephew
• Becton, Dickinson and Company (Bd)
• Braun Melsungen AG
• Cadence Inc.
• Integer Holdings Corp.
• Olympus Corp.
• Stryker
• Boston Scientific Corp.
• Erbe Elektromedizin GmbH
• 3M Healthcare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biochips Market to Undertake Strapping Growth By 2030

 Biochips Market Growth & Trends

The global biochips market size is expected to reach USD 25.92 billion by 2030, registering a CAGR of 13.35% during the forecast period, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.

Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.

The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.

The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.

Request a free sample copy or view report summary: Biochips Market Report

Biochips Market Report Highlights

• The DNA chips type segment accounted for the largest revenue share in 2021 due to the high demand for rapid and accurate detection of cancer
• The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
• The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2021 due to the need for personalized medicines along with the increasing drug discovery & development
• North America held the largest revenue share in 2021 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
• Asia Pacific is projected to register the fastest CAGR from 2022 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biochip-market

Biochips Market Segmentation

Grand View Research has segmented the global biochips market based on type, end-user, and region:

Biochips Type Scope Outlook (Revenue, USD Million, 2018 - 2030)

• DNA Chips
  • Cancer Diagnosis&Treatment
  • Gene Expression
  • SNP Genotyping
  • Genomics
  • Drug Discovery
  • Agricultural Biotechnology
  • Others
• Protein Chips
  • Proteomics
  • Expression Profiling
  • Diagnostics
  • HTS
  • Drug Discovery
  • Others
• Lab-on-chip
  • Genomics
  • IVD & POC
  • Proteomics
  • Drug Discovery
  • Others
• Tissue Arrays
• Cell Arrays

Biochips End-use Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology And Pharmaceutical Companies
• Hospitals And Diagnostics Centers
• Academic & Research Institutes
• Others

Biochips Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of the Key Players of Biochips Market

• Abbott Laboratories
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Fluidigm Corporation
• Illumina, Inc.
• GE Healthcare
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• LI-COR, Inc.
• Molecular Devices, LLC.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sales Training Software Market To Hold a High Potential for Growth by 2030: Grand View Research Inc.

 Sales Training Software Market Growth & Trends

The global sales training software market size is anticipated to reach USD 6.11 billion by 2030, registering a CAGR of 14.0% from 2022 to 2030, according to a new report by Grand View Research, Inc. The industry growth can be attributed to the paradigm shift in the focus of the incumbents of various end-use industries to reduce the time employees spend on repetitive tasks and devote the time saved to other customer engagement and relationship management activities. The sales training software can particularly help end-use enterprises in improving employee productivity, boosting product sales, and utilizing resources efficiently. Benefits associated with the adoption of such software include easy sales content creation and streamlined sales enablement.

The software also offers critical sales metrics measurements. Several organizations are looking to leverage advanced sales enablement solutions featuring technologies, such as Machine Learning (ML) & Artificial Intelligence (AI), to allow their sales and marketing teams more time to close deals and make connections. The AI-powered solution automates various tedious tasks in the sales training, such as generating analytics reports and drafting personalized content as per their interests, & business requirements. AI-driven sales training solutions offer sales teams easy mobile access to significant sales functions, which helps them achieve higher win rates and provide better experiences to prospects.

These advancements are expected to further boost the industry's growth during the forecast period. Key players are investing in R&D to develop innovative solutions to attract potential business clients and, thus, increase revenues. For instance, in October 2020, Highspot unveiled its sales enablement platform, which offers new sales training capabilities with a scorecard function for holistic evaluation and assessment of the sales personnel. The platform allows managers to create and manage virtual sales programs easily and train the sales team to meet sales targets. Managers can also obtain detailed insights into the performances of the sales personnel via a 360-degree analytics report.

Request a free sample copy or view report summary: Sales Training Software Market Report

Sales Training Software Market Report Highlights

• The cloud-based segment is expected to grow significantly from 2022 to 2030. Various companies are focusing on migrating their sales training software to a cloud platform to reduce maintenance costs and increase the revenue stream
• For instance, in April 2022, RAIN GROUP, a sales training company, collaborated with ValueCore, a cloud-based ROI platform company, to enable sales & marketing companies to represent entrancing value propositions to their customers
• The SME segment is expected to observe a rapid CAGR during the forecast period as SMEs are adopting sales training software to train their marketing & sales representatives to improve their brand identity worldwide in a minimum time
• The IT & telecom segment is anticipated to experience notable growth during the forecast period as the IT & telecom companies are focusing on increasing the customer retention rate through effective marketing & sales strategy
• Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 due to the increasing focus of end-use firms on sales training and enablement platforms to convert maximum leads into customers and stay competitive in their respective industries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sales-training-software-market

Sales Training Software Market Segmentation

Grand View Research has segmented the global sales training software market based on deployment, enterprise size, end-use, and region:

Sales Training Software Deployment Outlook (Revenue, USD Million, 2017 - 2030)

• Cloud
• On-premise

Sales Training Software Enterprise Size Outlook (Revenue, USD Million, 2017 - 2030)

• Large Enterprise
• Small & Medium Enterprise

Sales Training Software End-use Outlook (Revenue, USD Million, 2017 - 2030)

• BFSI
• Automotive
• Retail
• Healthcare
• IT & Telecom
• Discrete Manufacturing
• Government & Education
• Others (Hospitality, Consumer Goods, and Logistics & Transportation among others)

Sales Training Software Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players of Sales Training Software Market

• Allego
• Brainshark, Inc.
• Mindmatrix Inc.
• Mindtickle Inc.
• Qstream, Inc.
• Salesforce, Inc.
• SalesHood Inc.
• SAP SE
• Showpad
• Zoho Corp. Pvt. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Asia Pacific Food Grade Carbon Dioxide Market Expectations Acme Prominent Development in Developed Regions, Details Gvr Study

 Asia Pacific Food Grade Carbon Dioxide Market Growth & Trends

The Asia Pacific food grade carbon dioxide market size is expected to reach USD 673.07 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.8% from 2022 to 2030. Increasing usage of food-grade carbon dioxide for carbonation in carbonated beverage plants is anticipated to result in the growth of the market in the Asia Pacific. Moreover, the usage of food-grade carbon dioxide in meat processing and modified atmosphere packaging applications is anticipated to surge in the Asia Pacific region during the forecast period.

The demand for food-grade carbon dioxide is expected to increase in the meat industry owing to the increasing production and export of meat in the region. Carbon dioxide is used to preserve meat and prolong its shelf life. As carbon dioxide is an inert gas, it protects the meat from bacteria and preserves it for longer. Increasing disposable income in emerging countries of the region is expected to boost market growth during the forecast period.

In terms of revenue, the carbonation segment accounted for a share of 33.3% of the overall market in 2021. The growth of this segment can be attributed to the presence of leading carbonated beverage companies in the world opening bottling plants to cater to the growing demand in the region. The freezing and chilling application segment is expected to grow at a significant CAGR of 5.3% over the forecast period owing to the increasing import and export of frozen foods, thus stimulating the demand for cold storage.

In terms of revenue, the meat source segment is projected to grow at a CAGR of 6.6% during the forecasted period. Rising disposable incomes of consumers in the Asia Pacific region have increased the demand for meat and other frozen dairy items. The demand for food-grade carbon dioxide is expected to increase in Asia pacific as market players are opening new facilities to cater to the growing demand for meat.

China is one of the largest markets for carbon dioxide consumption globally owing to the large number of food exports in the country, which require carbon dioxide for preservation. According to the World Bank, food exports in China increased from 7.6% of the total exported merchandise to 9.1% from 2010 to 2021, thereby, boosting the demand for food-grade carbon dioxide.

The Asia Pacific food grade carbon dioxide market is moderately consolidated with the presence of various multinational players. The market is highly competitive as it requires significant initial investments for new research and development for new players to enter the market. Some of the significant players in the Asia Pacific food grade carbon dioxide market include Linde plc, Air Products Inc., and Air Liquide. Companies operating in this market have adopted merger and acquisition strategies to enhance their market share and expand their networks in the Asia Pacific region.

Request a free sample copy or view report summary: Asia Pacific Food Grade Carbon Dioxide Market Report

Asia Pacific Food Grade Carbon Dioxide Market Report Highlights

• The freezing & chilling segment held the largest revenue share of 39.85% in 2021, owing to an increase in the Asia Pacific food processing industry with many companies opening production facilities in the region
• In terms of revenue, the dairy and frozen products segment held the largest share of 31.90% in 2021. Increasing demand for prepackaged dairy and frozen products stimulated by increasing disposable income is expected to boost growth during the forecast period
• In terms of revenue, China accounted for a dominant revenue share of 38.51% in 2021. Increasing demand from the food export industry, coupled with increasing domestic consumption, is expected to augment the growth during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/asia-pacific-food-grade-carbon-dioxide-market-analysis

Asia Pacific Food Grade Carbon Dioxide Market Segmentation

Grand View Research has segmented the Asia Pacific food grade carbon dioxide market based on sources, application, and country:

Asia Pacific Food Grade Carbon Dioxide Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Freezing & Chilling
• Packaging
• Carbonation

Asia Pacific Food Grade Carbon Dioxide Sources Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Dairy and Frozen Products
• Beverages
• Meat
• Poultry
• Others

Asia Pacific Food Grade Carbon Dioxide Country Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Vietnam
  • Singapore
  • Thailand

List of Key Players in the Asia Pacific Food Grade Carbon Dioxide Market

• Air Liquide
• Air Products and Chemicals, Inc.
• Coregas
• Ellenbarrie Industrial Gases
• IFB Agro Industries Limited
• Linde plc
• Messer
• Sicgil India Limited
• Southern Gas Limited
• TAIYO NIPPON SANSO CORPORATION
• WKS Industrial Gas Pte Ltd

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.